Sensus Healthcare, Inc (SRTS) Stock Price

SRTSStock

$2.77−16.31%52W

Market Cap$45.60M

P/E9.63x

PEG Ratio—

Div yield—

Beta1.29

SRTS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-48.21%

Price vs S&P 500 (4W)-8.45%

VGM Score46.26

P/E Ratio (Annual)9.63x

P/CF (Annual)86.36x

Book Value / Share (Quarterly)$2.24

P/TBV (Annual)2.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-14.86%

Cash Flow / Share (Quarterly)$-0.42

Price vs S&P 500 (YTD)-42.33%

Gross Margin (TTM)36.39%

Net Profit Margin (TTM)-88.45%

EPS (TTM)$-0.94

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.94

Revenue Growth (5Y)23.46%

EPS (Annual)$-0.47

ROI (Annual)-16.05%

Gross Margin (Annual)43.18%

Net Profit Margin (5Y Avg)11.90%

Cash / Share (Quarterly)$0.92

Revenue Growth QoQ (YoY)-68.69%

P/E Normalized (Annual)9.63x

ROA (Last FY)-14.55%

Revenue Growth TTM (YoY)-53.40%

EBITD / Share (TTM)$-0.79

ROE (5Y Avg)12.62%

Operating Margin (TTM)-75.71%

Cash Flow / Share (Annual)$0.02

P/B Ratio1.24x

P/B Ratio (Quarterly)1.35x

Net Income / Employee (Annual)$-128,700

EV / Revenue (TTM)1.74x

Net Interest Coverage (TTM)-100.00x

ROA (TTM)-30.34%

EV / EBITDA (TTM)11.00x

EPS Incl Extra (Annual)$-0.47

Current Ratio (Annual)9.72x

Quick Ratio (Quarterly)4.30x

3-Month Avg Trading Volume0.03M

52-Week Price Return-16.31%

EV / Free Cash Flow (Annual)91.61x

Revenue / Employee (TTM)$291,800

Tangible BV / Share (Quarterly)$2.72

P/S Ratio (Annual)1.66x

Asset Turnover (Annual)0.52x

52-Week High$5.49

Operating Margin (5Y Avg)5.76%

EPS Excl Extra (Annual)$-0.47

CapEx CAGR (5Y)-11.45%

Tangible BV CAGR (5Y)33.89%

26-Week Price Return-38.31%

Quick Ratio (Annual)6.31x

13-Week Price Return-8.28%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.71x

Enterprise Value$30.41M

Revenue / Share Growth (5Y)23.62%

Asset Turnover (TTM)0.34x

Book Value / Share Growth (5Y)17.51%

Revenue / Employee (Annual)$458,000

Inventory Turnover (Annual)1.06x

Pretax Margin (Annual)-35.02%

Cash / Share (Annual)$1.34

3-Month Return Std Dev40.93%

Gross Margin (5Y Avg)57.72%

Net Income / Employee (TTM)$-258,100

ROE (Last FY)-16.05%

Net Interest Coverage (Annual)-27.22x

EPS Basic Excl Extra (Annual)$-0.47

P/FCF (TTM)8.47x

Receivables Turnover (TTM)2.45x

EV / Free Cash Flow (TTM)93.64x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.94

Receivables Turnover (Annual)2.13x

ROI (TTM)-34.09%

P/S Ratio (TTM)2.60x

Pretax Margin (5Y Avg)13.47%

Revenue / Share (Annual)$1.68

Tangible BV / Share (Annual)$2.93

Price vs S&P 500 (52W)-31.85%

Year-to-Date Return-30.40%

5-Day Price Return-5.46%

EPS Normalized (Annual)$-0.47

ROA (5Y Avg)10.51%

Net Profit Margin (Annual)-28.09%

Month-to-Date Return-7.36%

Cash Flow / Share (TTM)$-0.04

EBITD / Share (Annual)$-0.61

EPS Growth (3Y)17.62%

Operating Margin (Annual)-37.50%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)100.71x

ROI (5Y Avg)12.62%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.94

P/TBV (Quarterly)1.00x

P/B Ratio (Annual)1.36x

Inventory Turnover (TTM)0.65x

Pretax Margin (TTM)-72.53%

Book Value / Share (Annual)$2.92

Price vs S&P 500 (13W)-10.96%

Beta1.29x

P/FCF (Annual)137.35x

Revenue / Share (TTM)$1.06

ROE (TTM)-34.09%

52-Week Low$2.66

vGradeB

gGradeD

mGradeC

vgmGradeC

SRTS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.11	-$0.53	-381.82%(-$0.42)
Q1 2026	May 7, 2026	-$0.11	-$0.16	-45.45%(-$0.05)
Q4 2025	Feb 12, 2026	-$0.06	-$0.19	-245.45%(-$0.14)
Q3 2025	Nov 6, 2025	-$0.11	-$0.06	+45.45%(+$0.05)
Q2 2025	Aug 7, 2025	$0.01	-$0.06	-700.00%(-$0.07)

SRTS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.10

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SRTSSensus Healthcare, Inc	B	D	C	2.6x	23.5%	36.4%	-75.7%	$2.77
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Sensus Healthcare, Inc

Sensus Healthcare manufactures superficial radiotherapy (SRT) systems for treating skin cancers and non-cancerous skin conditions. The company's products, including the SRT-100 and SRT-100 Vision platforms, address dermatological applications such as basal cell carcinoma, squamous cell carcinoma, and keloids. Revenue is generated primarily from U.S. customers.

SRTS Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.04

Revenue estimate$6.61M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

SRTS Insider Transactions

BuyAug 31, 2026
SACHETTA ERIC
Director
Shares: 64,841Value: $225,616
BuyAug 27, 2026
SACHETTA ERIC
Director
Shares: 20,633Value: $66,682
BuyAug 24, 2026
SACHETTA ERIC
Director
Shares: 34,697Value: $112,904
BuyAug 21, 2026
SACHETTA ERIC
Director
Shares: 31,000Value: $97,850
BuyAug 20, 2026
SARDANO JOSEPH C
Chief Executive Officer
Shares: 20,000Value: $60,486

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

APTAlpha Pro Tech, Ltd.Orthopedic & Prosthetic Devices
COCHEnvoy Medical, Inc. Class A Common StockOrthopedic & Prosthetic Devices
MYOMyomo Inc.Orthopedic & Prosthetic Devices
POCIPrecision Optics Corporation, Inc. Common StockElectromedical Equipment
MBAIMBody AI Ltd. Ordinary ShareX-Ray Equipment
SYPRSypris Solutions IncIndustrial Instruments
MINDMIND Technology, Inc. Common Stock (DE)Defense Systems & Equipment
RPIDRapid Micro Biosystems, Inc. Class A Common StockLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$2.66

High$5.49